These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 21868574)

  • 1. Novel protein ADTRP regulates TFPI expression and function in human endothelial cells in normal conditions and in response to androgen.
    Lupu C; Zhu H; Popescu NI; Wren JD; Lupu F
    Blood; 2011 Oct; 118(16):4463-71. PubMed ID: 21868574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ADTRP regulates TFPI expression via transcription factor POU1F1 involved in coronary artery disease.
    Luo C; Pook E; Wang F; Archacki SR; Tang B; Zhang W; Hu JS; Yang J; Leineweber K; Bechem M; Huang W; Song Y; Cheung SH; Laux V; Ke T; Ren X; Tu X; Chen Q; Wang QK; Xu C
    Gene; 2020 Aug; 753():144805. PubMed ID: 32445923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen inhibits key atherosclerotic processes by directly activating ADTRP transcription.
    Luo C; Pook E; Tang B; Zhang W; Li S; Leineweber K; Cheung SH; Chen Q; Bechem M; Hu JS; Laux V; Wang QK
    Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2319-2332. PubMed ID: 28645652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caveolin-1 enhances tissue factor pathway inhibitor exposure and function on the cell surface.
    Lupu C; Hu X; Lupu F
    J Biol Chem; 2005 Jun; 280(23):22308-17. PubMed ID: 15817451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue factor pathway inhibitor in endothelial cells colocalizes with glycolipid microdomains/caveolae. Regulatory mechanism(s) of the anticoagulant properties of the endothelium.
    Lupu C; Goodwin CA; Westmuckett AD; Emeis JJ; Scully MF; Kakkar VV; Lupu F
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2964-74. PubMed ID: 9409283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen-dependent tissue factor pathway inhibitor regulating protein: a review of its peripheral actions and association with cardiometabolic diseases.
    Kee Z; Ong SM; Heng CK; Ooi DSQ
    J Mol Med (Berl); 2022 Feb; 100(2):185-196. PubMed ID: 34797389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into the Functional Role of ADTRP (Androgen-Dependent TFPI-Regulating Protein) in Health and Disease.
    Lupu C; Patel MM; Lupu F
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33923232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression, localization, and activity of tissue factor pathway inhibitor in normal and atherosclerotic human vessels.
    Crawley J; Lupu F; Westmuckett AD; Severs NJ; Kakkar VV; Lupu C
    Arterioscler Thromb Vasc Biol; 2000 May; 20(5):1362-73. PubMed ID: 10807755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a new
    Wang L; Wang X; Wang L; Yousaf M; Li J; Zuo M; Yang Z; Gou D; Bao B; Li L; Xiang N; Jia H; Xu C; Chen Q; Wang QK
    FASEB J; 2018 Jan; 32(1):183-194. PubMed ID: 28877957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caveolae optimize tissue factor-Factor VIIa inhibitory activity of cell-surface-associated tissue factor pathway inhibitor.
    Maroney SA; Ellery PE; Wood JP; Ferrel JP; Bonesho CE; Mast AE
    Biochem J; 2012 Apr; 443(1):259-66. PubMed ID: 22239091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligand-induced protease receptor translocation into caveolae: a mechanism for regulating cell surface proteolysis of the tissue factor-dependent coagulation pathway.
    Sevinsky JR; Rao LV; Ruf W
    J Cell Biol; 1996 Apr; 133(2):293-304. PubMed ID: 8609163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of tissue factor pathway inhibitor to lipid rafts is not required for inhibition of factor VIIa/tissue factor activity.
    Dietzen DJ; Jack GG; Page KL; Tetzloff TA; Hall CL; Mast AE
    Thromb Haemost; 2003 Jan; 89(1):65-73. PubMed ID: 12540955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of ADTRP (Androgen-Dependent Tissue Factor Pathway Inhibitor Regulating Protein) in Vascular Development and Function.
    Patel MM; Behar AR; Silasi R; Regmi G; Sansam CL; Keshari RS; Lupu F; Lupu C
    J Am Heart Assoc; 2018 Nov; 7(22):e010690. PubMed ID: 30571485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syndecan-3 and TFPI colocalize on the surface of endothelial-, smooth muscle-, and cancer cells.
    Tinholt M; Stavik B; Louch W; Carlson CR; Sletten M; Ruf W; Skretting G; Sandset PM; Iversen N
    PLoS One; 2015; 10(1):e0117404. PubMed ID: 25617766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of tissue factor-factor VIIa-catalyzed factor X activation by factor Xa-tissue factor pathway inhibitor. A rotating disc study on the effect of phospholipid membrane composition.
    Salemink I; Franssen J; Willems GM; Hemker HC; Lindhout T
    J Biol Chem; 1999 Oct; 274(40):28225-32. PubMed ID: 10497177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GATA2 regulates the CAD susceptibility gene ADTRP rs6903956 through preferential interaction with the G allele.
    Luo C; Tang B; Qin S; Yuan C; Du Y; Yang J
    Mol Genet Genomics; 2021 Jul; 296(4):799-808. PubMed ID: 33856550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronary artery disease susceptibility gene ADTRP regulates cell cycle progression, proliferation, and apoptosis by global gene expression regulation.
    Luo C; Wang F; Qin S; Chen Q; Wang QK
    Physiol Genomics; 2016 Aug; 48(8):554-64. PubMed ID: 27235449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adiponectin inhibits tissue factor expression and enhances tissue factor pathway inhibitor expression in human endothelial cells.
    Chen YJ; Zhang LQ; Wang GP; Zeng H; Lü B; Shen XL; Jiang ZP; Chen FP
    Thromb Haemost; 2008 Aug; 100(2):291-300. PubMed ID: 18690350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular effects of heparin on the production and release of tissue factor pathway inhibitor in human endothelial cells in culture.
    Lupu C; Poulsen E; Roquefeuil S; Westmuckett AD; Kakkar VV; Lupu F
    Arterioscler Thromb Vasc Biol; 1999 Sep; 19(9):2251-62. PubMed ID: 10479670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ixolaris, a novel recombinant tissue factor pathway inhibitor (TFPI) from the salivary gland of the tick, Ixodes scapularis: identification of factor X and factor Xa as scaffolds for the inhibition of factor VIIa/tissue factor complex.
    Francischetti IM; Valenzuela JG; Andersen JF; Mather TN; Ribeiro JM
    Blood; 2002 May; 99(10):3602-12. PubMed ID: 11986214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.